|

Developping a a Brain-controlled Art App to Ease Residual Symptoms of Depression

RECRUITINGN/ASponsored by Centre Hospitalier Universitaire de Besancon
Actively Recruiting
PhaseN/A
SponsorCentre Hospitalier Universitaire de Besancon
Started2024-10-10
Est. completion2025-02
Eligibility
Age25 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06098469

Summary

The study evaluate the effect of 10 neurofeedback sessions on the residual symptoms of depressive patients in partial remission.

Eligibility

Age: 25 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Subjects aged 25 to 65 included
* Information and signed informed consent
* Patients with a diagnosis of major depressive episode in remission
* MADRS score between 14 and 22
* Patients with residual symptoms as assessed by MADRS items
* No cognitive impairment.
* Right-handed

Exclusion Criteria:

* Subjects with legal incapacity or limited legal capacity
* Subjects unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator
* Pregnant women
* Subjects in the exclusion period of another study or is on the "national volunteer list".
* Subjects with another psychiatric pathology (bipolar mood disorder, psychosis, obsessive-compulsive disorder, addictive pathology, schizophrenia)
* Subjects under a protective measure such as guardianship or safeguard of justice.

Conditions1

Depression

Browse More Trials

Depression trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.